Novartis has joined Shinsei Corporate Investment, Seventure Partners, INCJ and Mitsubishi UFJ Capital in a $13.2m round for the cancer drug developer.

Mirexus, a biomaterials spinout of Guelph, will use the funding to support a new production facility.

The antibody replacement technology was co-developed by the California Institute of Technology.

Merck unit M Ventures co-led an $11.5m round for the antibody replacement technology developer with corporate-sponsored firm Legend Capital.

Existing investor Novo Ventures contributed to a series C round announced alongside Unchained Labs' acquisition of protein measurement device maker Trinean.

Asahi Kasei-backed biomaterials producer Mirexus will use the funding, supplied by investors including Goddard Enterprises subsidiary GEL Tech, to support a new production facility.

Nickelodeon, DMG Entertainment, Cali Group and Axiomatic took part in a series C round that lifted the eSports promoter's overall equity funding to $26m.

The international money transfer platform will use proceeds from the SBI-backed round to expand throughout Europe and into the US.

URWork has contributed to a $14.7m round for apartment rental portal Danke Apartment, which will use the capital to expand into three new Chinese markets.

The manufacturing services provider has now raised about $29m this year, after BMW i Ventures led a round that included existing investor GE Ventures.